Literature DB >> 23568192

Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility.

M Li1, X-J Luo2, M Rietschel3, C M Lewis4, M Mattheisen5, B Müller-Myhsok6, S Jamain7, M Leboyer8, M Landén9, P M Thompson10, S Cichon11, M M Nöthen12, T G Schulze13, P F Sullivan14, S E Bergen15, G Donohoe16, D W Morris16, A Hargreaves16, M Gill16, A Corvin16, C Hultman17, A W Toga10, L Shi18, Q Lin18, H Shi18, L Gan19, A Meyer-Lindenberg20, D Czamara6, C Henry8, B Etain21, J C Bis22, M A Ikram23, M Fornage24, S Debette25, L J Launer26, S Seshadri27, S Erk28, H Walter29, A Heinz30, F Bellivier31, J L Stein32, S E Medland33, A Arias Vasquez34, D P Hibar10, B Franke34, N G Martin35, M J Wright35, B Su18.   

Abstract

Bipolar disorder (BD) is a polygenic disorder that shares substantial genetic risk factors with major depressive disorder (MDD). Genetic analyses have reported numerous BD susceptibility genes, while some variants, such as single-nucleotide polymorphisms (SNPs) in CACNA1C have been successfully replicated, many others have not and subsequently their effects on the intermediate phenotypes cannot be verified. Here, we studied the MDD-related gene CREB1 in a set of independent BD sample groups of European ancestry (a total of 64,888 subjects) and identified multiple SNPs significantly associated with BD (the most significant being SNP rs6785[A], P=6.32 × 10(-5), odds ratio (OR)=1.090). Risk SNPs were then subjected to further analyses in healthy Europeans for intermediate phenotypes of BD, including hippocampal volume, hippocampal function and cognitive performance. Our results showed that the risk SNPs were significantly associated with hippocampal volume and hippocampal function, with the risk alleles showing a decreased hippocampal volume and diminished activation of the left hippocampus, adding further evidence for their involvement in BD susceptibility. We also found the risk SNPs were strongly associated with CREB1 expression in lymphoblastoid cells (P<0.005) and the prefrontal cortex (P<1.0 × 10(-6)). Remarkably, population genetic analysis indicated that CREB1 displayed striking differences in allele frequencies between continental populations, and the risk alleles were completely absent in East Asian populations. We demonstrated that the regional prevalence of the CREB1 risk alleles in Europeans is likely caused by genetic hitchhiking due to natural selection acting on a nearby gene. Our results suggest that differential population histories due to natural selection on regional populations may lead to genetic heterogeneity of susceptibility to complex diseases, such as BD, and explain inconsistencies in detecting the genetic markers of these diseases among different ethnic populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23568192      PMCID: PMC3937299          DOI: 10.1038/mp.2013.37

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  74 in total

1.  Gene expression and genetic variation data implicate PCLO in bipolar disorder.

Authors:  Kwang H Choi; Brandon W Higgs; Jens R Wendland; Jonathan Song; Francis J McMahon; Maree J Webster
Journal:  Biol Psychiatry       Date:  2010-12-24       Impact factor: 13.382

2.  Whole-genome association mapping of gene expression in the human prefrontal cortex.

Authors:  C Liu; L Cheng; J A Badner; D Zhang; D W Craig; M Redman; E S Gershon
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992

3.  Brain function in carriers of a genome-wide supported bipolar disorder variant.

Authors:  Susanne Erk; Andreas Meyer-Lindenberg; Knut Schnell; Carola Opitz von Boberfeld; Christine Esslinger; Peter Kirsch; Oliver Grimm; Claudia Arnold; Leila Haddad; Stephanie H Witt; Sven Cichon; Markus M Nöthen; Marcella Rietschel; Henrik Walter
Journal:  Arch Gen Psychiatry       Date:  2010-08

4.  Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder.

Authors:  Lars M Rimol; Cecilie B Hartberg; Ragnar Nesvåg; Christine Fennema-Notestine; Donald J Hagler; Chris J Pung; Robin G Jennings; Unn K Haukvik; Elisabeth Lange; Per H Nakstad; Ingrid Melle; Ole A Andreassen; Anders M Dale; Ingrid Agartz
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

5.  Genome-wide association study of major recurrent depression in the U.K. population.

Authors:  Cathryn M Lewis; Mandy Y Ng; Amy W Butler; Sarah Cohen-Woods; Rudolf Uher; Katrina Pirlo; Michael E Weale; Alexandra Schosser; Ursula M Paredes; Margarita Rivera; Nicholas Craddock; Mike J Owen; Lisa Jones; Ian Jones; Ania Korszun; Katherine J Aitchison; Jianxin Shi; John P Quinn; Alasdair Mackenzie; Peter Vollenweider; Gerard Waeber; Simon Heath; Mark Lathrop; Pierandrea Muglia; Michael R Barnes; John C Whittaker; Federica Tozzi; Florian Holsboer; Martin Preisig; Anne E Farmer; Gerome Breen; Ian W Craig; Peter McGuffin
Journal:  Am J Psychiatry       Date:  2010-06-01       Impact factor: 18.112

6.  Genetic linkage of region containing the CREB1 gene to depressive disorders in families with recurrent, early-onset, major depression: a re-analysis and confirmation of sex-specific effect.

Authors:  Brion S Maher; Hugh B Hughes; Wendy N Zubenko; George S Zubenko
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

7.  Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies.

Authors:  Tsun-Po Yang; Claude Beazley; Stephen B Montgomery; Antigone S Dimas; Maria Gutierrez-Arcelus; Barbara E Stranger; Panos Deloukas; Emmanouil T Dermitzakis
Journal:  Bioinformatics       Date:  2010-08-10       Impact factor: 6.937

8.  The stanley neuropathology consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers.

Authors:  Sanghyeon Kim; Maree J Webster
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Population genetic study of the brain-derived neurotrophic factor (BDNF) gene.

Authors:  T L Petryshen; P C Sabeti; K A Aldinger; B Fry; J B Fan; S F Schaffner; S G Waggoner; A R Tahl; P Sklar
Journal:  Mol Psychiatry       Date:  2009-03-03       Impact factor: 15.992

10.  The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia.

Authors:  E K Green; D Grozeva; I Jones; L Jones; G Kirov; S Caesar; K Gordon-Smith; C Fraser; L Forty; E Russell; M L Hamshere; V Moskvina; I Nikolov; A Farmer; P McGuffin; P A Holmans; M J Owen; M C O'Donovan; N Craddock
Journal:  Mol Psychiatry       Date:  2009-07-21       Impact factor: 15.992

View more
  35 in total

1.  Psychiatric genetics in China: achievements and challenges.

Authors:  Chunyu Liu; David Saffen; Thomas G Schulze; Margit Burmeister; Pak Chung Sham; Yong-Gang Yao; Po-Hsiu Kuo; Chao Chen; Yu An; Jiapei Dai; Weihua Yue; Miao Xin Li; Hong Xue; Bing Su; Li Chen; Yongyong Shi; Mingqi Qiao; Tiebang Liu; Kun Xia; Raymond C K Chan
Journal:  Mol Psychiatry       Date:  2015-10-20       Impact factor: 15.992

2.  Recent Positive Selection Drives the Expansion of a Schizophrenia Risk Nonsynonymous Variant at SLC39A8 in Europeans.

Authors:  Ming Li; Dong-Dong Wu; Yong-Gang Yao; Yong-Xia Huo; Jie-Wei Liu; Bing Su; Daniel I Chasman; Audrey Y Chu; Tao Huang; Lu Qi; Yan Zheng; Xiong-Jian Luo
Journal:  Schizophr Bull       Date:  2015-05-25       Impact factor: 9.306

3.  Common variants in the MKL1 gene confer risk of schizophrenia.

Authors:  Xiong-Jian Luo; Liang Huang; Edwin J van den Oord; Karolina A Aberg; Lin Gan; Zhongming Zhao; Yong-Gang Yao
Journal:  Schizophr Bull       Date:  2014-11-07       Impact factor: 9.306

4.  Association study of three single-nucleotide polymorphisms in the cyclic adenosine monophosphate response element binding 1 gene and major depressive disorder.

Authors:  Yange Wei; Shufang Bu; Xican Liu; Hengfen Li
Journal:  Exp Ther Med       Date:  2015-04-03       Impact factor: 2.447

Review 5.  Perspective on Etiology and Treatment of Bipolar Disorders in China: Clinical Implications and Future Directions.

Authors:  Zuowei Wang; Chen Jun; Keming Gao; Haichen Yang; Yiru Fang
Journal:  Neurosci Bull       Date:  2019-05-16       Impact factor: 5.203

Review 6.  Can data repositories help find effective treatments for complex diseases?

Authors:  Gregory K Farber
Journal:  Prog Neurobiol       Date:  2016-03-24       Impact factor: 11.685

7.  Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis.

Authors:  Kimm J E van Hulzen; Claus J Scholz; Barbara Franke; Stephan Ripke; Marieke Klein; Andrew McQuillin; Edmund J Sonuga-Barke; John R Kelsoe; Mikael Landén; Ole A Andreassen; Klaus-Peter Lesch; Heike Weber; Stephen V Faraone; Alejandro Arias-Vasquez; Andreas Reif
Journal:  Biol Psychiatry       Date:  2016-10-18       Impact factor: 13.382

Review 8.  Translational genomics and beyond in bipolar disorder.

Authors:  Chen Zhang; Xiao Xiao; Tao Li; Ming Li
Journal:  Mol Psychiatry       Date:  2020-05-18       Impact factor: 15.992

9.  Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1.

Authors:  Hong Chang; Lingyi Li; Tao Peng; Maria Grigoroiu-Serbanescu; Sarah E Bergen; Mikael Landén; Christina M Hultman; Andreas J Forstner; Jana Strohmaier; Julian Hecker; Thomas G Schulze; Bertram Müller-Myhsok; Andreas Reif; Philip B Mitchell; Nicholas G Martin; Sven Cichon; Markus M Nöthen; Stéphane Jamain; Marion Leboyer; Frank Bellivier; Bruno Etain; Jean-Pierre Kahn; Chantal Henry; Marcella Rietschel; Xiao Xiao; Ming Li
Journal:  Mol Neurobiol       Date:  2016-08-25       Impact factor: 5.590

10.  MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders.

Authors:  Zichao Liu; Liang Huang; Xiong-Jian Luo; Lichuan Wu; Ming Li
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.